Medical Devices Series A Investors & VC Firms
1128 firms in this list, with a median first check of $500K. 245 of them lead rounds. Generated from verified public data and updated continuously.
M Ventures
AmsterdamSeed–Growth$10.8M
12 people
Bluepoint Partners
DaejeonPre-Seed–Series A
50 people
SR One Capital Management
Redwood CitySeed–Series B
30 people
Hyundai Venture Investment Corporation
SeoulSeed–Series B$500K – $2M
OneVentures
SydneySeed–Growth$3.3M – $13.2M
40 people
Arboretum Ventures
Ann ArborSeed–Series A$5M – $15M
28 people
Olive Tree Capital
BostonSeed–Growth
6 people
Sandbox Industries
ChicagoSeed–Growth
34 people
Tech Square Ventures
AtlantaPre-Seed–Series A$500K – $3M
14 people
Angel Physicians Fund
Pre-Seed–Series A
44 people
Advent Life Sciences
LondonSeed–Series C
28 people
Cambridge Angels group
CambridgePre-Seed–Series A$195K – $1.9M
5 people
LIFTT
TorinoPre-Seed–Growth
36 people
Kfund
MadridPre-Seed–Series B$108K – $10.8M
27 people
Deepbridge Capital
ChesterSeed–Series A
25 people
S3 Ventures
AustinSeed–Series B$500K – $15M
12 people
Colle Capital Partners
New YorkPre-Seed–Series A$500K – $2M
28 people
GreatPoint Ventures
San FranciscoSeed–Series B$250K – $20M
15 people
Breyer Capital
AustinPre-Seed–Series A$500K – $10M
7 people
Aisling Capital
New YorkSeed–Series C
12 people
Norrsken VC
StockholmSeed–Series A$1.1M – $3.2M
24 people
Vensana Capital
MinneapolisSeries A–Late Stage
43 people
Medicxi
LondonSeed–Series B
38 people
Serra Ventures
ChampaignSeed–Series A$5M
18 people
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Series A Investors & VC Firms in United States (3839)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Series A Investors & VC Firms in Europe (2384)Fintech Series A Investors & VC Firms (2350)Healthtech Series A Investors & VC Firms (2310)Enterprise Software Series A Investors & VC Firms (2265)Series A Investors & VC Firms in Global (2211)
Data sourced from public filings and firms' own websites — see our methodology.







































































































